Article Text
Abstract
Advance directives for psychiatric care are the subject of debate in a number of Western societies. By using psychiatric advance directives (or so-called “Ulysses contracts”), it would be possible for mentally ill persons who are competent and with their disease in remission, and who want timely intervention in case of future mental crisis, to give prior authorisation to treatment at a later time when they are incompetent, have become non-compliant, and are refusing care. Thus the devastating consequences of recurrent psychosis could be minimised.
Ulysses contracts raise a number of ethical questions. In this article the central issues of concern and debate are discussed from a narrative perspective. Ulysses contracts are viewed as elements of an ongoing narrative in which patient and doctor try to make sense of and get a hold on the recurrent crises inherent in the patient's psychiatric condition.
- Medical ethics
- narrative ethics
- advance directives
- psychiatry
Statistics from Altmetric.com
Footnotes
-
Guy Widdershoven, PhD, is Professor in Ethics of Health Care at the Institute for Bioethics and Department of Health Ethics and Philosophy, Maastricht University, the Netherlands. Ron Berghmans, PhD, is Senior Researcher at the same institute.
Read the full text or download the PDF:
Other content recommended for you
- Ulysses Contracts in psychiatric care: helping patients to protect themselves from spiralling
- The Ulysses contract in obstetrics: a woman's choices before and during labour
- Contraceptive and sexual health care issues in women with schizophrenia
- Ethics of care challenge to advance directives for dementia patients
- Joint crisis plans and psychiatric advance directives in German psychiatric practice
- The validity of contracts to dispose of frozen embryos
- Limits of advance directives in decision-making around food and nutrition in patients with dementia
- Autonomy-based criticisms of the patient preference predictor
- Using coercion in mental disorders or risking the patient’s death? An analysis of the protocols of a clinical ethics committee and a derived decision algorithm
- Paediatric xenotransplantation clinical trials and the right to withdraw